CDT Equity Inc.
CDTTW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001896212
In the last 90 days, CDT Equity Inc. insiders filed 0 open-market purchases and 1 sale; 14 institutions reported holding it in 13F filings for Q2 2026, worth $81.8K in total; no superinvestor holds it.
Other share classesCDT
Q3 2025 vs. Q2 2025
How the institutions holding CDT Equity Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 17 | 1 | 17 | +1 |
| Shares | 5.93M | 534.9K | 5.93M | +530.8K (+9.8%) |
| Value | $62.4K | $5.83K | $61.9K | +$5.36K (+9.5%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held CDT Equity Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Clear Street Group Inc. | 534,562 | $5.67K | 0.00% |
| Susquehanna International Group, LLP | 108,092 | $1.16K | 0.00% |
| UBS Group AG | 622 | $7 | 0.00% |
Sold out (2)
Institutions that held CDT Equity Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Citadel Advisors LLC | 68,261 | $744 |
| Heights Capital Management, Inc | 45,923 | $501 |
Not filed for Q3 2025 yet (1)
Institutions that held CDT Equity Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Clear Street LLC | 534,933 | $5.83K |